MGC Pharmaceuticals Analysis
MGC Pharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of MGC Pharmaceuticals otc analysis is to determine its intrinsic value, which is an estimate of what MGC Pharmaceuticals is worth, separate from its market price. There are two main types of MGC Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The MGC Pharmaceuticals otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and MGC Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
MGC |
MGC OTC Stock Analysis Notes
The company recorded a loss per share of 0.01. MGC Pharmaceuticals had not issued any dividends in recent years. MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia. Mgc Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for MGC Pharmaceuticals is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about MGC Pharmaceuticals contact Roby Zomer at 61 8 6382 3390 or learn more at https://mgcpharma.com.au.MGC Pharmaceuticals Investment Alerts
| MGC Pharmaceuticals is not yet fully synchronised with the market data | |
| MGC Pharmaceuticals has some characteristics of a very speculative penny stock | |
| MGC Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| MGC Pharmaceuticals has accumulated 4.35 M in total debt with debt to equity ratio (D/E) of 0.84, which is about average as compared to similar companies. MGC Pharmaceuticals has a current ratio of 0.82, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist MGC Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, MGC Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MGC Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MGC to invest in growth at high rates of return. When we think about MGC Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 4.65 M. Net Loss for the year was (20.35 M) with profit before overhead, payroll, taxes, and interest of 562.87 K. | |
| MGC Pharmaceuticals has accumulated about 1.89 M in cash with (12.16 M) of positive cash flow from operations. |
MGC Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MGC Pharmaceuticals's market, we take the total number of its shares issued and multiply it by MGC Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.MGC Pharmaceuticals Outstanding Bonds
MGC Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. MGC Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most MGC bonds can be classified according to their maturity, which is the date when MGC Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding MGC Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in MGC OTC Stock
If you are still planning to invest in MGC Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MGC Pharmaceuticals' history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |